Live

Pfizer, Inc. Common Stock (PFE) congressional disclosures

Healthcare · coverage Jan 8, 2024–Aug 7, 2026

Create a PFE watch
Tracked disclosures
39
Lawmakers
21
Reported purchase / sale rows
17 / 22A disclosure count, not congressional market sentiment

Estimated market comparison · not an official filing fact

Available with Pro

Average post-trade price move across enriched rows. It is historical, sample-limited, does not account for exact execution prices or portfolio weights, and is not evidence that the filing activity caused a market move.

Disclosure alert preview

Based on a real public filing

Sale

Michael A. Rulli

PFEPfizer, Inc. Common Stock

$1K - $15K

Traded
Nov 26, 2024
Filed
Aug 7, 2026
Disclosure delay
619 days
Reported owner
Not normalized

This watch matched after the disclosure became public. It is not a real-time trade signal. Source checked Aug 13, 2026.

Official filing

PFE congressional trades snapshot

This page summarizes public STOCK Act disclosures involving PFE. It is useful for seeing which lawmakers reported PFE transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.

Last updated

Aug 7, 2026

Data source

Public House and Senate STOCK Act disclosures normalized by Congressional Trader.

Key caveat

Filing date can trail transaction date. This page is for research and monitoring, not investment advice.

What the PFE congressional trade page shows

Congressional Trader tracks 39 public STOCK Act disclosures for PFEacross 21 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.

The most recent PFE filing shown here was filed on Aug 7, 2026 by Michael A. Rulli as a sale. Related lawmakers include Gilbert Ray Cisneros, Jared Moskowitz, Kathy E. Manning, Robert P. Bresnahan, Roger Williams.

FAQ

Which lawmakers traded PFE?

Recent PFE disclosures include Gilbert Ray Cisneros, Jared Moskowitz, Kathy E. Manning, Robert P. Bresnahan, Roger Williams.

What is the buy/sell mix for PFE?

The visible sample currently shows 17 purchases and 22 sales or partial sales.

Should I trade based on PFE disclosures?

No. This page summarizes public filings for research and monitoring. It is not investment advice.